West Pharmaceutical (WST) PT Lowered to $285 at UBS
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $341.11 --0%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Join SI Premium – FREE
UBS analyst Gregg Orrill lowered the price target on West Pharmaceutical (NYSE: WST) to $285.00 (from $390.00) while maintaining a Buy rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- JPMorgan Downgrades Industrial Bank Co Ltd (601166:CH) to Neutral
- Japan Tobacco Inc. (2914:JP) (JAPAY) PT Raised to JPY8,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
